You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Anna M. Chiarelli

Senior Scientist, Cancer Control & Evidence Integration, Clinical Institutes and Quality Programs, Ontario Health

Senior Scientist
anna.chiarelli@ontariohealth.ca

Research Interests

  • Effectiveness of breast cancer screening tests
  • Breast screening in high-risk women
  • Clinical effects of delays on diagnosis
  • Effectiveness of individualized breast screening
  • Improvement in breast cancer risk stratification tools

Current Appointments

  • Senior Scientist, Screening Program Design, Prevention and Cancer Control, Clinical Institutes and Quality Programs, Ontario Health
  • Provincial Lead Scientist, Ontario Breast Screening Program, Ontario Health
  • Professor, Dalla Lana School of Public Health, University of Toronto

Education and Credentials

  • PhD, Epidemiology, University of Toronto
  • MHSc, Community Health and Epidemiology, University of Toronto
  • BSc, Biology, University of Toronto

Achievements

  • First Prize Poster Award, International Cancer Screening Network Meeting, June 2015
  • ACE (Achievement, Commitment, Excellence) Award for Cross Functional Teams, “Computed Radiography Mammography Replacement Project,” Ontario Ministry of Health and Long Term Care, 2013–14
  • ACE (Achievement, Commitment, Excellence) Award for Cross Functional Teams, “Expansion of the Ontario Breast Cancer Screening Programs to women at high risk of breast cancers,” Ontario Ministry of Health and Long Term Care, 2011–2012
  • Graduate Student Prize Paper Award, Canadian Society for Epidemiology and Biostatistics, June 1997
  • A.H. Sellers PhD Fellowship, Cancer Care Ontario, 1991 to 1993

Skills and Experience

  • Principles of epidemiology to design, conduct, and analyze population-based health service and evaluation research studies
  • Breast cancer epidemiology, including incidence, mortality and trends
  • Principles of organized cancer screening theory (lead time, selection bias), screening test characteristics (PPV, sensitivity) and strategies for data collection and management (use of appropriate databases, linkage to appropriate registries, classification of screening outcomes, quality control procedures)

Selected Publications

 

Brooks JD, Mah A, Christensen RAG, Arneja J, Eisen A, Chiarelli AM. Validation of the International Breast Cancer Intervention Study (IBIS) Model in the High Risk Ontario Breast Screening Program: A Retrospective Cohort Study. Genet Med. 2023 Mar 12:100820. doi: 10.1016/j.gim.2023.100820. Epub ahead of print. PMID: 36919844.

Lapointe J, Côté JM, Mbuya-Bienge C, Dorval M, Pashayan N, Chiquette J, Eloy L, Turgeon A, Lambert-Côté L, Brooks JD, Walker MJ, Blackmore KM, Joly Y, Knoppers BM, Chiarelli AM, Simard J, Nabi H. Canadian Healthcare Professionals' Views and Attitudes toward Risk-Stratified Breast Cancer Screening. J Pers Med. 2023 Jun 21;13(7):1027. doi: 10.3390/jpm13071027. PMID: 37511640.

Mavaddat N, Ficorella L, Carver T, Lee A, Cunningham AP, Lush M, Dennis J, Tischkowitz M, Downes K, Hu D, Hahnen E, Schmutzler RK, Stockley TL, Downs GS, Zhang T, Chiarelli AM, Bojesen SE, Liu C, Chung WK, Pardo M, Feliubadaló L, Balmaña J, Simard J, Antoniou AC, Easton DF. Incorporating alternative Polygenic Risk Scores into the BOADICEA breast cancer risk prediction model. Cancer Epidemiol Biomarkers Prev. 2023 Jan 13:EPI-22-0756. doi: 10.1158/1055-9965.EPI-22-0756. Epub ahead of print. PMID: 36649146.

Mittmann N, Blackmore KM, Seung SJ, Diong C, Done SJ, Chiarelli AM. Healthcare and Cancer Treatment Costs of Breast Screening Outcomes among Higher than Average Risk Women. Curr Oncol. 2023 Sep 18;30(9):8550-8562. doi: 10.3390/curroncol30090620. PMID: 37754535.

For a full list of Anna M. Chiarelli's journal articles, visit PubMed.